Zoetis management check
ZTS · Health Care · Pharmaceuticals · CEO Kristin C. Peck
Filings as of
Closest peers in Pharmaceuticals
- 35LLYLilly (Eli)84
- 181JNJJohnson & Johnson70
- 195ZTSZoetis68
- 261MRKMerck & Co.64
- 277PFEPfizer63
- 335BMYBristol Myers Squibb59
- 369VTRSViatris57
The seven checks
- FlagTrailed its chosen peers
Have owners done well?
What $100 became since fiscal 2021
016thDetail
$100 invested at the start of fiscal 2021 grew to $80, against $188 for the peer group the company picked itself.
- GoodPay rose and fell with returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
9378thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.87 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- Good0.7% of net income
What does the CEO cost owners?
$19.0m pay · $2.7bn net income, FY2025
6262ndDetail
$19.0m of reported pay in fiscal 2025, against $2.7bn of net income.
- n/aNo recent CEO filing
Do they own the stock?
——No open-market insider buying or selling in the last six months.
- GoodShare count shrinking
Are owners being diluted?
Diluted shares −2.0% a year; flagged above +2%
Stock pay 0.9% of revenue
7567thDetail
Diluted shares changed -2.0% a year over the last three fiscal years. Stock-based pay was 0.9% of revenue in the latest year.
- Good9 leadership filings in 3 years
Is leadership stable?
9 filings under 8-K 5.02 in 3 years
CEO: Kristin C. Peck
8056thDetail
CEO in the pay table: Kristin C. Peck. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- GoodNo red flags on file
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 010-K amended
100100thDetail
No restatements, auditor changes or late filings since 2021.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed April 8, 2026.
Pay tied most to Revenue
Other key measuresRelative Total Shareholder ReturnAdjusted Diluted EPSFree Cash Flow
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Kristin C. Peck | $19.0m | $2.8m | $4.0m | $80 | $188 | $2.7bn |
| 2024 | — | $17.2m | $760k | $3.4m | $102 | $148 | $2.5bn |
| 2023 | — | $15.2m | $26.4m | $3.0m | $122 | $137 | $2.3bn |
| 2022 | — | $14.0m | −$15.7m | $2.9m | $90 | $136 | $2.1bn |
| 2021 | — | $13.1m | $33.5m | $4.5m | $148 | $126 | $2.0bn |
Insiders and the CEO's stakeQuiet
No open-market insider buying or selling in the last six months.
Open-market trades by officers and directors since May 21, 2026.
Leadership and governance on file
All 13 filings
- Oct 13, 2026Leadership change8-K 5.02
- Aug 6, 2026Leadership change8-K 5.02
- May 22, 2026Leadership change8-K 5.02
- Oct 28, 2025Leadership change8-K 5.02
- May 22, 2025Leadership change8-K 5.02
- May 24, 2024Leadership change8-K 5.02
- May 23, 2024Leadership change8-K 5.02
- Apr 16, 2024Leadership change8-K 5.02
- Apr 1, 2024Leadership change8-K 5.02
- Feb 7, 2023Leadership change8-K 5.02
- Oct 25, 2022Leadership change8-K 5.02
- Jul 25, 2022Leadership change8-K 5.02
- Apr 21, 2022Leadership change8-K 5.02
Latest shareholder vote results: May 22, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $8.5bn returned to owners in buybacks and dividends, 73% of net income, and $337.0m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $7.8bn | $8.1bn | $8.5bn | $9.3bn | $9.5bn |
| Net income | $2.0bn | $2.1bn | $2.3bn | $2.5bn | $2.7bn |
| Stock-based pay | $58.0m | $62.0m | $60.0m | $74.0m | $83.0m |
| Buybacks | $743.0m | $1.6bn | $1.1bn | $1.9bn | $3.2bn |
| Dividends | — | — | — | — | — |
| Diluted shares | 477m | 470m | 462m | 455m | 444m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.